OneMedNet Shrinks Liabilities, Bets on Palantir AI for Data Access

Event summary

  • OneMedNet reduced total liabilities by approximately $19.6 million, a 75% reduction year-over-year.
  • The company integrated Palantir’s AI platform (AIP) to accelerate platform development and launch an AI-driven multimodal subscription search.
  • OneMedNet expanded its healthcare provider network by 37% year-over-year, reaching 186 million clinical exams across 2,130 sites.
  • Third quarter bookings increased eightfold year-over-year from 2024 to 2025.

The big picture

OneMedNet is positioning itself to capitalize on the growing demand for Real-World Data (RWD) driven by the rise of AI in healthcare and the increasing acceptance of RWE by regulators. The partnership with Palantir represents a significant bet on AI-powered data analytics, but also introduces a dependency on a key vendor. The company’s focus on subscription-based access models signals a shift away from traditional data licensing, aiming for more predictable and recurring revenue streams.

What we're watching

Execution Risk
The success of OneMedNet’s strategy hinges on the effective integration of Palantir’s AIP and the rapid adoption of its new AI-driven platform, which could face technical or market challenges.
Customer Retention
While repeat orders and MSAs are positive indicators, the company must demonstrate sustained customer loyalty and expansion within the life sciences and healthcare sectors to justify the investment in the platform.
Regulatory Shifts
The increasing reliance on Real-World Evidence (RWE) by regulatory bodies like the FDA and EMA creates both opportunity and risk, as changes in guidelines could impact OneMedNet’s business model and growth trajectory.

Related topics

Technology